Jacobs Levy Equity Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-293,500
| Closed | -$3.16M | – | 1031 |
|
|
2023
Q1 | $3.16M | Sell |
293,500
-30,237
| -9% | -$325K | 0.02% | 482 |
|
|
2022
Q4 | $4.85M | Buy |
323,737
+6,291
| +2% | +$94.2K | 0.03% | 401 |
|
|
2022
Q3 | $4.08M | Buy |
+317,446
| New | +$4.08M | 0.03% | 434 |
|
|
2021
Q3 | – | Sell |
-47,178
| Closed | -$657K | – | 1086 |
|
|
2021
Q2 | $657K | Sell |
47,178
-3,335
| -7% | -$46.4K | ﹤0.01% | 819 |
|
|
2021
Q1 | $935K | Buy |
50,513
+11,119
| +28% | +$206K | 0.01% | 751 |
|
|
2020
Q4 | $696K | Sell |
39,394
-2,386
| -6% | -$42.2K | 0.01% | 804 |
|
|
2020
Q3 | $640K | Sell |
41,780
-3,377
| -7% | -$51.7K | 0.01% | 744 |
|
|
2020
Q2 | $1.15M | Sell |
45,157
-4,367
| -9% | -$111K | 0.01% | 641 |
|
|
2020
Q1 | $767K | Sell |
49,524
-8,103
| -14% | -$125K | 0.01% | 685 |
|
|
2019
Q4 | $637K | Buy |
+57,627
| New | +$637K | 0.01% | 756 |
|